• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 543658 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1418995917 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1418995917 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Halozyme Therapeutics Crosses Above its 10-day MA (HALO)

Published on Wed, 07/31/2013 - 12:13
By Mallory Stone

Halozyme Therapeutics (NASDAQ:HALO) shares have crossed bullishly above their 10-day moving average of $8.36 on a volume of 420K shares. This may provide swing traders with an opportunity for a long position, as such a crossover often suggests higher prices in the near term.

Halozyme Therapeutics, Inc. develops and commercializes recombinant human enzymes for the infertility, ophthalmology, and oncology communities. The Company's product portfolio is based on intellectual property covering the family of human enzymes known as hyaluronidases. Halozyme's products offer an alternative to slaughterhouse-derived extracts that carry contamination risks.

Halozyme Therapeutics (NASDAQ:HALO) has potential upside of 16.9% based on a current price of $8.62 and analysts' consensus price target of $10.07. The stock should find initial support at its 50-day moving average (MA) of $7.38 and further support at its 200-day MA of $6.43.

Halozyme Therapeutics share prices have moved between a 52-week high of $13.50 and a 52-week low of $3.86 and are now trading 123% above that low price at $8.62 per share. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has risen 0.4%.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Ventas had the Lowest Relative Performan...

Here are 5 stocks in the Specialized REITs industry ranked by performance. We compiled ...

Bottom 5 Companies in the Specialized Fi...

Here are 5 stocks in the Specialized Finance industry ranked by performance. We compil ...

Short-term Underperformance Detected in ...

Below are five companies in the Semiconductors industry that underperformed yesterday o ...

Shares of FormFactor Underperformed its ...

Here are 5 stocks in the Semiconductor Equipment industry ranked by performance. We co ...

Bottom 5 Companies in the Retail REITs I...

Here are 5 stocks in the Retail REITs industry ranked by performance. We compiled the ...

Bottom 5 Companies in the Restaurants In...

Below are five companies in the Restaurants industry that underperformed yesterday on a ...

Analysis of Relative Performance in the ...

Below are five companies in the Residential REITs industry that underperformed yesterda ...

Short-term Underperformance Detected in ...

Analysis was conducted on the Reinsurance industry to measure relative performance to f ...